title: FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
authors.forename: Rachel
authors.initials: R
authors.lastname: Morra
authors.forename: Pascal
authors.initials: P
authors.lastname: Lebray
authors.forename: Patrick
authors.initials: P
authors.lastname: Ingiliz
authors.forename: Yen
authors.initials: Y
authors.lastname: Ngo
authors.forename: Mona
authors.initials: M
authors.lastname: Munteanu
authors.forename: Vlad
authors.initials: V
authors.lastname: Ratziu
authors.forename: Thierry
authors.initials: T
authors.lastname: Poynard
mesh_terms: D001219:Aspartate Aminotransferases / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000175:diagnosis* / Q000821:virology; D010976:Platelet Count; D011379:Prognosis
chemical_list: D015415:Biomarkers; D001219:Aspartate Aminotransferases